Top Medical News from Across Medscape

  • Trump and GOP 'Pull' House Bill to Replace ACAA vote on the bill was postponed for the second day in a row as President Trump and House Speaker Ryan could not win over enough Republican critics for passage.
  • Medicare Spells Out CGM Coverage for DiabetesThe Dexcom G5 Mobile is currently the only continuous glucose monitor (CGM) approved for making 'therapeutic' decisions, rendering it reimbursable as durable medical equipment under Medicare.
  • Parking Lot Lung Cancer Screening Pays DividendsA pilot project of CT-based lung cancer screening, based in a supermarket parking lot, showed that rates of early lung cancer detection were raised fourfold.
  • CHMP Backs Trumenba for Meningococcal Disease PreventionThe Committee for Medicinal Products for Human Use recommended marketing authorization for Trumenba for immunization against invasive disease caused by meningococcal serogroup B bacteria.
  • NCCN Updates Lung Cancer Guideline, AgainChange and more change is happening in lung cancer, and the National Comprehensive Cancer Network (NCCN) is keeping pace in its guidelines.

Special Report

  • The whirlwind pace of proposed changes to the US healthcare system makes it almost impossible for one person to keep up.  Let us do it for you.

Business of Medicine

  • Are You Leaving Tax Money on the Table? Are you still working on your tax returns? Here are some important ways to get all of the deductions you deserve.
  • The State Shouldn't Tell Doctors What to Say, Says Ethicist   Dr Art Caplan, bioethicist, discusses physicians' right to talk to their patients about certain topics, including gun safety and the abortion reversal pill, in view of various state legislation.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California